Compare Appian Corp (APPN) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Appian Corp vs GeneDx Holdings Corp — how do they compare? Appian Corp trades at $35.5 (market cap $2.54B), while GeneDx Holdings Corp trades at $82.5 (market cap $2.44B). The key difference: Appian Corp and GeneDx Holdings Corp are close in size by market cap, and Appian Corp is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| APPN | WGS | |
|---|---|---|
Market Cap | $2.54B | $2.44B |
Sector | Technology | Technology |
52-Week High | $45.64 | $167.51 |
52-Week Low | $18.72 | $34.51 |
Enterprise Value | $2.67B | $2.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Appian Corp
Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.
Read more on APPN →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
